Panel Discussion: How Will Diagnostics Change With the NIA-AA Revised Criteria for Diagnosis & Staging of Alzheimer’s Disease?
Time: 5:30 pm
day: Conference Day One
Details:
- Shifting Alzheimer’s Disease definitions to more biological than clinical definitions
- Integrating the latest validated findings in plasma-based marker research to establish likelihood of developing AD
- Exploring how the novel staging might affect diagnosis and staging to understand the potential impact on clinical research
